Lichtenstein A - Search Results

1

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.

Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Nemeth E, et al. Among authors: lichtenstein a. Blood. 2003 Apr 1;101(7):2461-3. doi: 10.1182/blood-2002-10-3235. Epub 2002 Nov 14. Blood. 2003. PMID: 12433676 Free article.

2

Involvement of hepcidin in the anemia of multiple myeloma.

Sharma S, Nemeth E, Chen YH, Goodnough J, Huston A, Roodman GD, Ganz T, Lichtenstein A. Sharma S, et al. Among authors: lichtenstein a. Clin Cancer Res. 2008 Jun 1;14(11):3262-7. doi: 10.1158/1078-0432.CCR-07-4153. Clin Cancer Res. 2008. PMID: 18519751

3

In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2.

Maes K, Nemeth E, Roodman GD, Huston A, Esteve F, Freytes C, Callander N, Katodritou E, Tussing-Humphreys L, Rivera S, Vanderkerken K, Lichtenstein A, Ganz T. Maes K, et al. Among authors: lichtenstein a. Blood. 2010 Nov 4;116(18):3635-44. doi: 10.1182/blood-2010-03-274571. Epub 2010 Aug 2. Blood. 2010. PMID: 20679527 Free PMC article.

4

The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma.

Vescio RA, Hong CH, Cao J, Kim A, Schiller GJ, Lichtenstein AK, Berenson RJ, Berenson JR. Vescio RA, et al. Among authors: lichtenstein ak. Blood. 1994 Nov 15;84(10):3283-90. Blood. 1994. PMID: 7524734 Free article. Clinical Trial.

5

Defensins: antimicrobial and cytotoxic peptides of mammalian cells.

Lehrer RI, Lichtenstein AK, Ganz T. Lehrer RI, et al. Among authors: lichtenstein ak. Annu Rev Immunol. 1993;11:105-28. doi: 10.1146/annurev.iy.11.040193.000541. Annu Rev Immunol. 1993. PMID: 8476558 Review.

6

In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes.

Lichtenstein A, Ganz T, Selsted ME, Lehrer RI. Lichtenstein A, et al. Blood. 1986 Dec;68(6):1407-10. Blood. 1986. PMID: 3779104 Free article.

7

The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element.

An J, Lichtenstein AK, Brent G, Rettig MB. An J, et al. Blood. 2002 Jan 15;99(2):649-54. doi: 10.1182/blood.v99.2.649. Blood. 2002. PMID: 11781250 Free article.

8

Production of cytokines by bone marrow cells obtained from patients with multiple myeloma.

Lichtenstein A, Berenson J, Norman D, Chang MP, Carlile A. Lichtenstein A, et al. Blood. 1989 Sep;74(4):1266-73. Blood. 1989. PMID: 2475182 Free article.

9

Multiple myeloma clones are derived from a cell late in B lymphoid development.

Berenson JR, Vescio RA, Hong CH, Cao J, Kim A, Lee CC, Schiller G, Berenson RJ, Lichtenstein AK. Berenson JR, et al. Among authors: lichtenstein ak. Curr Top Microbiol Immunol. 1995;194:25-33. doi: 10.1007/978-3-642-79275-5_4. Curr Top Microbiol Immunol. 1995. PMID: 7534671

10

Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts.

Vescio RA, Han EJ, Schiller GJ, Lee JC, Wu CH, Cao J, Shin J, Kim A, Lichtenstein AK, Berenson JR. Vescio RA, et al. Among authors: lichtenstein ak. Bone Marrow Transplant. 1996 Jul;18(1):103-10. Bone Marrow Transplant. 1996. PMID: 8832002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

842 results

Search Page